Heyang Cui
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Surgery top 5%
- Esophageal Cancer Research and Treatment
Papers in
- Surgery 24
- Esophageal Cancer Research and Treatment 24
-
- Cancer Genomics and Diagnostics 7
- Co-authors
- Yongping Cui (17 shared papers)Pengzhou Kong (6 shared papers)Yanghui Bi (7 shared papers)Ting Yan (4 shared papers)Yu Qian (4 shared papers)Yikun Cheng (4 shared papers)Xiaolong Cheng (3 shared papers)Weimin Zhang (8 shared papers)
- Journals
- The American Journal of Human Genetics (5 papers)Cancer Letters (3 papers)Nature Communications (2 papers)Oncotarget (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaHong KongUnited States
In The Last Decade
Heyang Cui
34 papers receiving 1.4k citations
Heyang Cui's Hit Papers
Peers
Comparison fields: 5 of 71
- Cancer Research 271
- Surgery 588
- Oncology 285
- Molecular Biology 393
- Otorhinolaryngology 30
Countries citing papers authored by Heyang Cui
This map shows the geographic impact of Heyang Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heyang Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heyang Cui more than expected).
Fields of papers citing papers by Heyang Cui
This network shows the impact of papers produced by Heyang Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heyang Cui. The network helps show where Heyang Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Heyang Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic Analyses Reveal Mutational Signatures and Frequently Altered Genes in Esophageal Squamous Cell Carcinoma Hit paper breakdown → | 2015 | 290 |
| 2 | Whole-genome sequencing of 508 patients identifies key molecular features associated with poor prognosis in esophageal squamous cell carcinoma Hit paper breakdown → | 2020 | 197 |
| 3 | 2022 | 132 | |
| 4 | 2019 | 119 | |
| 5 | 2016 | 109 | |
| 6 | 2017 | 91 | |
| 7 | 2016 | 73 | |
| 8 | 2020 | 36 | |
| 9 | 2023 | 36 | |
| 10 | 2019 | 33 | |
| 11 | 2020 | 32 | |
| 12 | 2012 | 31 | |
| 13 | 2020 | 31 | |
| 14 | 2018 | 24 | |
| 15 | 2015 | 22 | |
| 16 | 2023 | 22 | |
| 17 | 2015 | 21 | |
| 18 | 2015 | 21 | |
| 19 | 2020 | 19 | |
| 20 | 2013 | 16 |
About Heyang Cui
Heyang Cui is a scholar working on Surgery, Cancer Research, Oncology, Cell Biology and Molecular Biology, having authored 39 papers that have together received 1.5k indexed citations. Recurring topics across this work include Esophageal Cancer Research and Treatment (24 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Glycosylation and Glycoproteins Research (3 papers), Microtubule and mitosis dynamics (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Cancer Cells and Metastasis (2 papers) and Cellular Mechanics and Interactions (2 papers). The work is most often cited by research in Cancer Research (271 citations), Surgery (588 citations), Oncology (285 citations), Molecular Biology (393 citations) and Otorhinolaryngology (30 citations). Heyang Cui has collaborated with scholars based in China, Hong Kong and United States. Frequent co-authors include Yongping Cui, Pengzhou Kong, Yanghui Bi, Ting Yan, Yu Qian, Yikun Cheng, Xiaolong Cheng, Weimin Zhang, Caixia Cheng and Yanchun Ma. Their work appears in journals such as The American Journal of Human Genetics, Cancer Letters, Nature Communications, Oncotarget and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.